Complex Autoantibody Responses Occur Following Moderate to Severe Traumatic Brain Injury
Edward Needham(University of Cambridge), Alasdair Coles(University of Cambridge), Hani S. Mousa(University of Cambridge), Elisa R. Zanier(Mario Negri Institute for Pharmacological Research), Oda Stoevesandt(University of Tübingen), Kaj Blennow(Sahlgrenska University Hospital), Faiez Al Nimer(Karolinska Institutet), David Menon(University of Cambridge), Peter J. Hutchinson(University of Cambridge), Virginia Newcombe(Pace University), Joanne Jones(University of Cambridge), Joanne Outtrim(University of Cambridge), Fredrik Piehl(Karolinska University Hospital), Eric Peter Thelin(Karolinska University Hospital), Adel Helmy(University of Cambridge), Zhihui Yang Z(Allen Institute for Brain Science), Kevin Wang(Kavli Energy NanoScience Institute), M.J. Taussig(ARVYS Proteins (United States)), Nicholas J. Ashton(King's College London), Henrik Zetterberg(University of Wisconsin System), Joel Simrén(University of Gothenburg)
Cited by 6
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation
|Medical Image Analysis|2016|3.5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k